Close Menu

Thermo Fisher Scientific Oncomine Childhood Cancer Research Assay

Apr 16, 2018

Thermo Fisher Scientific has launched the Oncomine Childhood Cancer Research Assay, a next-generation sequencing panel developed in collaboration with Children's Hospital Los Angeles that specifically targets mutations associated with pediatric and young adult cancers. The assay combines specific mutations, gene amplifications, and fusions over 203 genes representing multiple gene classes, and 1,700 fusion transcripts in two DNA and two RNA pools. The assay is designed to integrate with the Ion Chef system for automated library preparation and amplification, as well as the Ion GeneStudio S5 system and Ion Reporter for bioinformatics and reporting.

More Like This

Oct 15, 2019

HTG Molecular HTG EdgeSeq Autoimmune Panel

HTG Molecular said it is now taking orders for its new HTG EdgeSeq Autoimmune Panel, which it expects to commercially launch in kit form or as a service at the end of October. The firm said it has designed the panel to address questions around autoimmune disorders, as well as for examining immune system dysfunction, discovering new biomarkers, and discovering predictive signatures of drug responses in the autoimmune space. 

Oct 15, 2019

Magbio Genomics HighPrep Total RNA Plus Kit

Magbio Genomics has successfully developed the HighPrep Total RNA Plus Kit, a RNA purification chemistry for Mawi DNA Technologies' iSwab-RNA-V2 collection tool. According to Mawi, researchers isolating RNA from iSwab-RNA-v2 using HighPrep will have high-quality RNA yield in the range of 1-4 µg per sample. In addition, Mawi said that both tools can be fully automated on industry platforms including the Hamilton MicroLabStar. 

Oct 15, 2019

Paragon CleanPlex Hereditary Cancer Panel V2

Paragon Genomics has launched its CleanPlex Hereditary Cancer Panel V2. The Haywood, California-based firm said that updated version of the platform halves the number of required primer pools, reducing the required DNA sample size and further increasing ease of use. 

Oct 15, 2019

Qiagen QIAseq FastSelect RNA Removal Products

Qiagen has launched the QIAseq FastSelect -rRNA and -Globin HMR Kits, which are designed to remove more than 97 percent of ribosomal RNA and globin messenger RNA from human, mouse, and rat samples to optimize RNA sequencing.

Qiagen also launched the QIAseq FastSelect 5S/16S/24S Kit to remove abundant bacterial 5S/16S/24S rRNA from RNAseq libraries prepared from complex microbial communities in soil, water, stool, and sludge samples.

The company noted that its QIAseq FastSelect kits remove unwanted RNA with a single 10-second pipetting step and 14 minutes of incubation.

Oct 15, 2019

Loop Genomics Transcriptomics Service

Loop Genomics has launched a targeted, long-read, single-cell transcriptomics service that couples Illumina sequencing instruments with probe capture and cDNA from single cells to generate long-read data. The service includes Loop's computational pipeline that reconstructs the long-read transcripts from clouds of barcoded short reads and provides researchers with actionable reports, the company said.

Oct 14, 2019

PercayAI CompBio

PercayAI, a recently launched spinout of the Genome Technology Access Center at the McDonnell Genome Institute at Washington University School of Medicine in St. Louis, has introduced its first product, CompBio. Featuring augmented intelligence technology, CompBio is meant to help identify relationships within multi-omic datasets to inform drug discovery. The new company said that the software harnesses neural networks, deep learning, and heuristics so that the machine learns from humans as humans learn from the machine. 

Oct 14, 2019

Claret Bioscience SRSLY NGS Library Prep Kit

Claret Bioscience of Santa Cruz, California has launched a directional NGS library preparation kit called SRSLY (Single Reaction Single-stranded LibrarY). SRSLY is a single-stranded approach to library preparation, and can be fine-tuned based on user preference to capture a substantial fraction of short DNA fragments. By foregoing end-polishing, the method also retains the native 5' and 3' ends of each template molecule, providing a precise snapshot of fragmentation products, the company said. The kit's main applications are to help cell-free DNA researchers analyze nucleosome positioning and to aid investigators in producing higher-quality sequencing libraries from degraded DNA sources such as FFPE samples.

Oct 14, 2019

Predictive Laboratories FertilityDX

Predictive Laboratories launched FertilityDX, a genetic testing service that allows physicians to tailor fertility treatments. The test provides information in three areas, the firm said — causes of infertility, risks of pregnancy complications, and risks for serious genetic conditions in the offspring. As part of the service patients are provided pretest counseling, and physicians received an easy-to-understand final report, as well as access to genetic consultants. 

Oct 14, 2019

PerkinElmer PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit

PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Anueploidy kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment. Preimplantation genetic testing for aneuploidiy is used to identify viable embryos and has typically involved a biopsy by creating an opening in the outer coating prior to removal and testing a few cells. Recent studies have demonstrated, however, that an embryo releases small amounts of DNA into the culture media in which it is growing, allowing for the surrounding fluid to be genetically tested. PerkinElmer's kit tests the spent embryo culture to detect aneuploidies and structural rearrangements, including unbalanced translocations and segmental errors.

Oct 11, 2019

Sema4 Expanded Carrier Screening

Sema4 has launched a larger Expanded Carrier Screen for family planning with personalized residual risk.

The test analyzes 502 genes associated with clinically relevant conditions, up from 283 genes, to cover more rare diseases. The test detects more high-risk pregnancies and identifies up to 30 times more carrier couples, Sema4 CEO Eric Schadt said in a statement. It also incorporates low-pass genome analysis to detect ancestry markers that to refine the accuracy of results.

Oct 11, 2019

Dante Labs Whole Genome, Whole GenomeZ Sequencing Service

Dante Labs has launched its Whole Genome and WholeGenomeZ sequencing test services. The firm said that the service — located at its Illumina-backed, Italy-based automated sequencing center — offers reports and raw data for users with a two-week turnaround time. According to Dante Labs, the Premium Whole Genome costs €899 (or $949) for the fastest turnaround time versus €599 (or $649) for the standard turnaround time. The price for the Super Premium Whole GenomeZ is €1,399 (or $1,499) for the fast turnaround time, and €899 (or $999) for the standard turnaround time. 

Oct 10, 2019

Predictive Laboratories ARTguide Test

Salt Lake City, Utah-based Predictive Laboratories has commercially launched its ARTguide DNA-based blood test, which examines the risk for endometriosis and other genetic causes of infertility in women. According to the firm, the test identifies hundreds of genetic markers of endometriosis and 80 other additional mutations causing conditions that may impact fertility.  

Oct 10, 2019

Co-Diagnostics Vector Smart ZDC Test

Co-Diagnostics has commercially launched its Vector Smart ZDC test, which is used to identify the presence of Zika, dengue, and chikungunya in mosquito populations. The firm said that its line of Vector Smart PCR products are validated using extractions from mosquito samples to reduce the possibility of a false negative result due to improper extraction. 

Oct 01, 2019

NanoString nCounter Human Organ Transplant Panel

NanoString Technologies has launched its nCounter Human Organ Transplant panel, a new gene expression panel for evaluating the immune response following organ transplantation. The firm said that it created the assay in collaboration with the Banff Foundation for Allograft Pathology. The panel covers 770 genes and is customizable. It is designed for use with the predominant transplant organs including kidney, heart, lung, and liver. Genes included on the panel are involved in 37 pathways that are components of the immune response, tissue injury, and mechanisms of action for immunosuppressive drugs. The panel also includes probes to detect common viral infections that can cause issues with transplants, including BK polyomavirus, cytomegalovirus, and Epstein-Barr virus.

Oct 01, 2019

Ambry Genetics +RNAinsight

Ambry Genetics has launched +RNAinsight, a combined DNA and RNA genetic test for hereditary cancer syndromes that is designed to return more certain results to patients by using RNA sequencing to definitively classify otherwise ambiguous genetic alterations. While the RNA aspect of the test does not include all known cancer risk genes, it does focus on a subset that includes BRCA1 and 2, TP53, PTEN, and PALB2, among others. Ambry said that the turnaround time for the combined test matches the company's DNA-only hereditary cancer panel.

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.

Oct
21
Sponsored by
Agilent

Genomics is a key element in the potential of precision medicine to transform oncology. 

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
04
Sponsored by
Roche

This webinar will provide a look at how the Institute of Hematopathology in Hamburg, Germany, is implementing complex genomic testing for lung cancer.